
from
Independent International Investment Research3 page report
published Oct 23, 2009
Price
$15.00 available for immediate download
Report Overview
Search Inside
About
Independent International Inve...
Dr. Reddy Laboratories Limited (Dr. Reddy) recorded a significant y-o-y increase in revenues in 2Q 10, primarily due to strong revenue growth in the Global Generic segment...
|
| Source: | IIR Group PLC
|
| Document ID: | GER25521NJ
|
| Country: | India
|
| Industry: | Pharmaceutical
|
| Ticker: | 500124=IN
|
| Primary ISIN: | US2561352038
|
| Primary Sedol: | 2748881
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Independent International Investment Research is the UK's leading source of truly impartial research and strategy for global equities and currencies.